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1. Introduction
Looking at the historic contributions of i.a. Galvani and Edgar 
Adrian [1], it is clear that the coupling of human-made elec-
tric devices to the nervous system is a centuries-old topic. 
Nevertheless, brain-machine interfacing and in particular the 
pursuit of long-lasting, high-speed, high-resolution direct 
electrical communication with the brain is still a major chal-
lenge for scientists and engineers.
Plenty of work has pushed the state of the art forwards. Such 
work includes the introduction of monolithic needle probes or 
needle probe arrays penetrating the brain surface [2–6] and flex-
ible electrode arrays for measuring microelectrocorticographic 
(µECOG) signals on the brain surface [7, 8]. More recently, 
versions of both needle probe arrays and µECOG arrays that 
include integrated electronics have been demonstrated as well, 
improving the channel count even  further [9–12].
However, increasing the channel count is not the only issue 
to solve as scar tissue tends to build up around the implant. 
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Abstract
Objective. This study investigates the suitability of a thin sheet of extracellular matrix 
(ECM) proteins as a resorbable coating for temporarily reinforcing fragile or ultra-low 
stiffness thin-film neural implants to be placed on the brain, i.e. microelectrocorticographic 
(µECOG) implants. Approach. Thin-film polyimide-based electrode arrays were fabricated 
using lithographic methods. ECM was harvested from porcine tissue by a decellularization 
method and coated around the arrays. Mechanical tests and an in vivo experiment on rats were 
conducted, followed by a histological tissue study combined with a statistical equivalence 
test (confidence interval approach, 0.05 significance level) to compare the test group with an 
uncoated control group. Main results. After 3 months, no significant damage was found based 
on GFAP and NeuN staining of the relevant brain areas. Significance. The study shows that 
ECM sheets are a suitable temporary coating for thin µECOG neural implants.
Keywords: coatings, resorbable carrier, ECM, temporary reinforcement, ECOG,  
neural implants
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This increases the distance between the viable neural tissue 
and the implant, increases the contact impedance and lim-
its the ultimate resolution [13]. An important insight in the 
strive towards well-performing high-resolution chronic neural 
implants has been the discovery of the detrimental effects of 
motion of the implant with respect to the brain, which is much 
softer than any artificial electrode structure [14, 15]. Therefore, 
researchers have introduced ‘floating’ needle implants that are 
attached to the outside by a flexible connector [16, 17], or have 
emphasized the importance of mechanically flexible implants. 
If an implant is made so flexible that insertion becomes prob-
lematic, this can be resolved by temporary reinforcement by 
a biocompatible water-soluble or resorbable material, or with 
another type of temporary reinforcement [18–21]. An alterna-
tive is injection while dispersed in a liquid [22].
A second important aspect that causes the buildup of scar 
tissue is the response of the immune system to the implant’s 
surface, which is perceived as a foreign body. Several 
approaches to limit this effect have been published, including 
the release of cortisones [23] and the coating of the implant 
with molecules such as laminin [24, 25] or neuron-specific 
adhesion factors such as L1 [26].
In this work, we will study the use of extracellular matrix 
(ECM) proteins in neural implants positioned on the brain. 
We will show the potential of thin ECM sheets as temporary 
reinforcement material that allows inserting implants too fine 
to support themselves during insertion. The ECM naturally 
occurs as a scaffold structural support for the body’s cells in 
all tissue types and also plays an important function in cell 
signaling, acting e.g. as a reservoir for growth factors [27]. 
ECM sheets can be harvested from animal tissue by a variety 
of decellularization processes [28], and can then be used in 
a range of tissue engineering applications. ECM proteins are 
highly conserved across mammalian species and when prop-
erly decellularized these biologic scaffolds are well accepted 
by the body, even if the source tissue is xenogenic. For exam-
ple, biologic scaffolds derived from porcine small intestine 
submucosa (SIS) are commercially available for use in human 
surgery [29]. ECM coatings have also been shown to reduce 
the chronic inflammatory response to implanted polypropyl-
ene meshes [30]. Moreover, a hydrogel based on porcine blad-
der ECM has also been applied successfully in animal tests 
to reduce damage after traumatic brain injury [31]. Recently, 
neural tissue-based ECM has also come under investigation 
for that target application though the in vivo performance does 
not yet clearly exceed that of non-neural ECM [32, 33]. SIS 
ECM has been used successfully as dura mater repair material 
[34]. Based on the latter results, we have selected SIS for use 
in our neural implant coating experiment as environment it is 
applied in is the same.
2. Methods
2.1. Neural implant design
The implants used as in the test and control group of this study 
were designed to be used for electric measurements and stimu-
lation in cavities in the brain in a related research project [35].
These electrode array implants are composed of ‘islands’ 
that carry one electrode each and are connected with spring-
like structures that also contain the conductors to allow bend-
ability and in-plane stretchability. The implants consist of two 
layers of polyimide (PI) insulation, between which platinum 
conductors and electrodes are sandwiched. The electrode 
arrays were designed using finite element (FE) simulation to 
have similar flexibility and stretchability as those of a previ-
ous generation with lower area [21]. The area of the designed 
electrode array excluding the connector is 5  ×  5 mm2.
The implants are 7 µm thick in total and therefore very 
flexible, but still strong enough to be used without reinforcing 
coating. Therefore, implants not coated with ECM can serve 
as a reference in the in vivo experiments. This does not defeat 
the purpose of the experiment which is to show that the ECM 
material can be used as biocompatible temporary reinforce-
ment: an even thinner PI structure will show similar or bet-
ter biocompatibility behavior when ECM-coated because the 
surface properties will be the same and possible mechanical 
irritation will only be lower.
The layout of the electrode arrays is shown in figure 1. This 
figure also shows a 4  ×  4 electrode array resulting from the 
fabrication process, after it has been lifted off from the wafer 
it was fabricated on and an Omnetics connector was mounted.
The lithographic process used to fabricate the electrode 
arrays is detailed in another publication [36]. Basically, a sili-
con substrate is coated with an aluminum sacrificial layer on 
which the first PI layer (Dupont PI2611) is deposited by spin 
coating and partially cured by heating it to 200 °C. This was 
shown to lead to an improved insulation performance com-
pared to a full curing of the layer at this step [36]. Then, the 
platinum conductors are deposited by sputtering and patterned 
by a liftoff process. Thereafter, the second PI layer is depos-
ited and the assembly is fully cured by heating to 350 °C. In 
a further step, the PI layers are patterned and the electrode 
contacts are opened using reactive ion etching. Then, the 
devices are removed from the carrier wafer. In a final step, the 
Omnetics connector is mounted by soldering and the connec-
tor pins and bond pads are electrically insulated using H54 
epoxy cured at 150 °C for 1 h.
2.2. Neural implant coating
SIS ECM sheets were isolated from freshly harvested porcine 
gut tissue by mechanically scraping off the surrounding tis-
sues, followed by rinsing in 0.1% peracetic acid and PBS as 
previously described [37] in more detail. After production, 
the SIS was freeze dried and stored until needed for implant 
coating. Before coating, the implant was disinfected with 
70% isopropyl alcohol. A single SIS sheet was then cut to a 
size 2 mm larger than the outline of the implant, rehydrated 
with saline and wrapped around the implant such that it would 
cover both sides. The abluminal side of the SIS was placed 
facing inside. The laminate was then put on a block of porous 
glass, covered with a Teflon foil and put in a vacuum chamber 
for drying while a pressure of about 1 bar was applied by put-
ting an appropriate steel block on top, coated with anti-stick 
Teflon spray. The drying time was 3 h. After drying, the SIS 
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coating was cut to a size about 0.5 mm larger than the out-
line of the electrode array using surgical scissors. A coated 
implant is shown in figure 2. Before implantation, the coated 
implants were sterilized using ethylene oxide vapor for 20 h 
at 38 °C.
2.3. Micromechanical testing
In order to assess the level of mechanical reinforcement 
obtainable by ECM coating as described, four additional elec-
trode arrays were fabricated and coated using the procedure 
outlined in sections 2.1 and 2.2. The dimensions of the coating 
layer were measured using a caliper and mechanical thickness 
gauge.
Four uncoated implants were taken as a reference. The con-
nector and hind part of the samples were glued to an aluminum 
oxide substrate, leaving the electrode array part sticking out 
over the edge of the substrate. A Femtotools FTA-M02 micro-
mechanical testing device (figure 3) was then used to displace 
the freestanding part of the samples in the out-of-plane direc-
tion and measure the reaction force during displacement. Out-
of-plane loading mimics the forces on the implant during and 
after insertion well, as is clear from figure 4. The underlying 
bending stiffness k (equaling applied force/displacement) was 
determined from these measurements by linear interpolation. 
The Young’s modulus E of the materials was then determined 









With I the area moment of inertia:




In these equations, L is the distance between the support and 
the contact point of the indenter tip, b is the measured width 
of the sample and h is the sample thickness. The ECM thick-
ness was to be measured for every sample as there is a cubic 
dependence and the thickness can be expected to vary as the 
ECM is from a natural source. As the stiffness of the coat-
ing is orders of magnitude higher than the stiffness of the 
uncoated implant, the presence of the latter in the center of 
the coating can be ignored when determining the mechani-
cal properties of the coated implants. The basic shape of the 
uncoated implants is more complicated than a simple beam. 
Figure 1. Left: layout of the 4  ×  4 electrode array used. Lower middle: cross section. Top right: fabricated electrode array, wrapped around 
a 2 mm diameter mock nerve. Configuration of electrode and wires is well visible. Lower right: assembled electrode array.
Figure 2. Coated implant.
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Therefore, finite element simulation (Comsol Multiphysics, 
Mindlin plate 2D model) was used to determine the Young’s 
modulus there with more precision, supplementing the simple 
beam approximation.
2.4. In vivo experiments
In vivo experiments were performed on male Wistar rats 
(n  =  18) weighing approximately 250 g upon arrival. They 
were housed in pairs, separated from each other by a cage 
divider, in an animal room with a 14:10 light:dark cycle (lights 
on at 07h00) and a constant temperature of 20 °C. Animals 
received ad libitum food and water. The research project was 
in accordance with the Belgian and European laws, guidelines 
and policies for animal experimentation, housing and care 
(Belgian Royal Decree of 29 May and European Directive 
2010/63/EU on the protection of animals used for scientific 
purposes of 20 October 2010). Rats were divided into a test 
group (n  =  9), which received an ECM-coated implant as 
described above and a control group (n  =  9) that received a 
non-coated implant.
They were anesthetized with a mixture of ketamine (Nimatek, 
Eurovet Animal Health B.V., Bladel, The Netherlands; 60 mg 
kg−1; i.p.) and medetomidine hydrochlorate (NarcoStart, Kela 
Veterinaria NV, Sint-Niklaas, Belgium; 0.2 mg kg−1; i.p.) and 
were then secured in a stereotactic frame. A burr hole was made 
over the primary motor cortex of the right brain hemisphere at the 
following coordinates: A  =  3 mm; P  =  2 mm; L  =  0.5–4.5 mm. 
The electrode was then implanted on the dura mater, which is 
very thin in rats, overlying the healthy motor cortex. The coated 
electrodes were moistened with saline before implantation. 
After implantation, the electrode array was covered with a layer 
of Kwik-Sil silicone (World Precision Instruments, USA) after 
which the bore hole and connector were enclosed using UV 
curing dental cement (Nanofil Flowable AT&M Biomaterials 
Co., Beijing, China), after which the skin was sutured. The 
rats received pain medication and remained on a heating plate 
(36 °C) until regaining consciousness. A schematic of the elec-
trode placement is shown in figure 4.
Three animals of each group were perfused at the follow-
ing time points: one week post implantation, 3 weeks post 
implantation, 13 weeks post implantation. Animals were per-
fused intracardially, first with 10% sucrose in distilled water 
and then with 4% formaldehyde in distilled water. The brains 
were dissected and submerged in 4% formaldehyde in dis-
tilled water during 24 h after which they were transferred to 
a 20% sucrose solution with sodium azide. The samples were 
kept at 4 °C until cryosection. After fast freezing at  −50 °C 
on the cryostat chuck, twenty micron thick cryosections were 
made at a temperature of  −20 °C.
2.5. GFAP and NeuN staining
GFAP and NeuN staining was then used to test for a potential 
increase in glial cell density (immune response) and to com-
pare viable neuron densities, respectively. For this purpose, 
we used the following protocol: after rehydration in PBS, the 
sections were incubated in 20% goat serum and 0.2% Triton 
X-100 for 2 h. Then, a mixture of 1:100 mouse NeuN antibody 
dilution and a 1:500 rabbit GFAP antibody dilution was added 
and incubated overnight. Then, the mixture was removed and 
the slides were washed 3 times in PBS for 15 min. Then the 
secondary antibodies, Alexa Fluor 568 goat anti-mouse and 
Alexa Fluor 633 goat anti-rabbit (both in 1:500 dilution) were 
added and incubated for 2 h. The secondary antibodies were 
then washed away in PBS in two steps of 10 min. Before 
finally attaching a coverslip, the sections were coated with a 
drop of Vectashield DAPI.
2.6. Data analysis
After staining, samples were inspected using a confocal laser 
scanning microscope. A 4.2 mm  ×  2.5 mm frame central-
ized under the location of the implant was imaged with 8-bit 
Figure 3. Measuring bending stiffness using the Femtotools 
FTA-M02 micromechanical testing device. Inset: close-up of 
indenter tip with force sensor, pushing down on the electrode array.
Figure 4. Graph showing how the implant is positioned on the 
brain.




Coating thickness (µm) 211 18
Bending stiffness, uncoated (N m−1) 0.019 0.004
Bending stiffness, coated (N m−1) 10.6 4.1
Young’s Modulus of PI (GPa) 7.7 1.8
Young’s modulus of ECM (GPa) 0.15 0.04
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grayscale color depth, as well as the corresponding untouched 
contralateral area of the brain on the same section to be used as 
the reference. In the analyses, the ratio between the averaged 
intensity of the left and right image was used, which reduces 
the effect of slide-to-slide variation. Furthermore, before aver-
aging, a set threshold was applied to reduce background noise. 
In the case of the GFAP stain, the threshold was determined ad 
hoc based on the intensity histogram of the parts of the image 
outside the tissue by selecting a value that removed most of 
this background noise, i.e. three standard deviations from the 
peak center of the average histogram. In the case of the NeuN 
stain, the threshold was increased until the neural cell bodies, 
which are normally clearly visible, start to disappear.
In order to statistically test for equivalence, the common 
confidence interval approach [38] was used at the 0.05 sig-
nificance level. The test requires the definition of an equiva-
lence interval. If the confidence interval (CI) of the difference 
between the averages of the test and control group fully lies 
within the equivalence interval, the two groups are considered 
equivalent. The equivalence interval was set at  ±10%. To esti-
mate the number of degrees of freedom of the combination of 
the two groups, which is necessary for the equivalence test, 
the Welch-Satterthwaite equation was used.
3. Results
3.1. Mechanical measurements
Measurements were performed such as described in section 2.3 
and summarized in table  1. The measurements showed that 
the uncoated implants had an average thickness of 7 µm, ver-
sus 211 µm for the coated implants. The average width of the 
coating layer was 5.7 mm. Micromechanical testing revealed 
an average bending stiffness of 0.019 N m−1 for the uncoated 
implants. Coating increased this average bending stiffness 558 
fold to 10.6 N m−1 (figure 5). By fitting the measurements on 
a finite element model as described in section 2.3 the Young’s 
modulus of the polyimide was determined to be 7.7 GPa. This 
lies within the range of values reported in the literature, 5.8–
8.5 GPa [39, 40]. The Young’s modulus of the ECM layer was 
measured to be only 0.15 GPa. Thus, the reinforcement effect 
of the coating is mainly due to its thickness.
3.2. Histology
During dissection of the brain, we observed that the burr hole 
was closed entirely with new bone tissue. The implanted elec-
trode array was always found attached to the inside surface of 
the regrown bone and was not connected firmly to the brain. 
Therefore, the histological slices made for analysis do not 
contain the electrode itself. Still, as observed in our previous 
work, an implant positioned in this way can cause significant 
neural damage if e.g. an inflammation reaction is present [21].
Visual inspection of the histological slides revealed no 
appreciable brain damage, which normally manifests itself as 
a cavity under the implant location. Examples are shown in 
figure 6. It should be noted that in our previous work, in which 
we used a chitosan coating instead of an ECM coating, such 
a cavity was present [21]. An exception was seen in two rats 
that were euthanized one week after electrode implantation. 
Only in these rats we noticed significant bleeding in the brain 
during surgery which is therefore the most likely cause of the 
damage. As the test group became too small when leaving out 
the two rats, we did not analyze the 7 samples further.
After imaging the slides by laser confocal microscopy, image 
processing and data analysis was done as described in section 2. 
The intensity threshold value was set using the procedure out-
lined before, which resulted in a value of 60 for the NeuN stain 
and 25 for the GFAP stain. The intensity measurements are 
summarized in figure 7 (3 weeks after implant ation) and figure 8 
(3 months after implantation). In these figures, the left column 
shows the measured intensities per group and per hemisphere 
while the right column shows the ratio between the intensity 
in the right hemisphere—where the implant was located—and 
the untouched left hemisphere of the rats. The ratios are clearly 
showing much less variation than the absolute data. The 95% 
confidence interval of the GFAP ratios lies above 1 both for the 
Figure 5. Measured applied displacement versus measured force 
for a non-coated (top graph) and a coated (bottom graph) implant. 
The red line shows the linear fit of the data.
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test and control group, indicating an increased glial cell response 
in both groups. However, the equivalence test shows that there is 
no significant difference in glial cell response between the non-
ECM coated control group and the test group within the speci-
fied range of  ±10%. The difference between the means is just 
a few percent. Furthermore, the graphs show no indication of a 
decreased neuron density based on the NeuN stain after 3 weeks 
as well as after 3 months. Finally, the neuron density in the test 
and the control groups is shown to be statistically equivalent.
4. Discussion
A group of ECM-coated thin film neural implants was com-
pared with a non-coated control, in a situation where the 
implants were put directly on the dura of the brain. Based 
on confidence intervals at the 0.05 significance level with an 
equivalence range of  ±10%, we conclude that the viability 
of nearby neurons and glial cell response were not different 
between the test and control group. Visual inspection of brain 
slices also did not show any cavities or other signs of damage. 
Therefore, the presented technique is a good candidate for 
temporarily supporting neural implants that are by themselves 
too flexible to be inserted into the body without support.
The investigated period of three months is sufficient, as most 
of the ECM will be absorbed by the body in two months [41]. 
Compared with most temporary reinforcement mat erials found 
in the literature cited in the introduction (silk, carboxymethyl 
cellulose, chitosan) the constituents of the ECM will be the very 
same the intracellular environment naturally contains and will 
elicit a benign response. Another advantage is that ECM sheets 
are already commercially available, approved for human use.
There are several aspects that are left for further invest-
igation. As with all coatings, the presence of the temporary 
ECM layer can influence the electrode performance shortly 
Figure 6. Example pictures of resulting immunohistological staining. No obvious brain damage in the form of cavities is visible after 3 
months. NeuN stain is green, GFAP is red. Top: rat from the test group. Bottom: from control group.
Figure 7. Analysis results for samples taken after 3 weeks, showing NeuN (top row) and GFAP (bottom row) measured intensities. The 
left graphs display the measurements for the two hemispheres separately (average and standard deviation shown), while the right graphs 
show the average ratio between the measured intensity right and left per group, together with the 95% confidence interval. CI range, 
the combined range of the test and control CIs, lies within the predefined equivalence range. Therefore, test and control groups can be 
considered equivalent.
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after implantation. Therefore, the electrical performance 
of the implants should be compared with that of uncoated 
implants in a longitudinal study. A second point for further 
study is the application of temporary reinforcement with ECM 
in a more challenging environment such as directly in the 
brain parenchyma, in a healthy or diseased region. For exam-
ple, in other recent work, it was shown that bladder-derived 
ECM gel injected in the brain is well tolerated and can even 
reduce lesion size after trauma [31]. Therefore, it is possible 
that ECM coating reduces trauma caused by insertion in the 
brain. This could also be the case in existing brain trauma, 
such as lesion cavities formed after hemorrhage.
The coating material used does not need to be limited to 
the already commercially available and well-studied material 
used here. Several research groups work on improving the 
state of the art of regenerative medicine for the brain and study 
new scaffold materials specific for neural applications. The 
group of new materials under study comprises both natural, 
decellularized neural tissue [42] as well as newly synthesized 
hydrogel materials [43, 44].
As the methods shown in this paper can be adapted to other 
coating materials, results of the current research in  regenerative 
medicine for the brain can possibly be put to use to improve 
neural interfacing devices as well. Moreover, regenerative 
medicine research could also benefit from  integrating elec-
trodes in implanted scaffolds as they allow real-time study of 
electrical signals.
5. Conclusion
In short, the current work indicates that ECM sheets are a 
suitable temporary coating material for reinforcing thin neural 
implants that are to be placed on the brain. Coating of neural 
implants with materials investigated in regenerative medi-
cine research is not only a promising way to improve neural 
interfacing devices, but also opens up new prospects for mul-
timodal regenerative medicine research in which electrical 
measurements or stimulation are combined with bioactive 
scaffolds for inducing and studying tissue regeneration.
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